{"id": "IEPA.d2.s2_IEPA.d2.s2.p8", "text": "SP ewes also had greater incorporation of [3H]inositol into inositol trisphosphate (IP3) (+3449%, p less than 0.01) and total inositol phosphate (IP) (+760%, p less than 0.08), in response to oxytocin, than did oCSP ewes (+553 and +168% for IP3 and total IP, respectively) in endometrium collected at ovariectomy/hysterectomy on Day 16", "text_with_entity_marker": "SP ewes also had greater incorporation of [3H]inositol into inositol trisphosphate (IP3) (+3449%, p less than 0.01) and total inositol phosphate (IP) (+760%, p less than 0.08), in response to [E1]oxytocin[/E1], than did oCSP ewes (+553 and +168% for IP3 and total [E2]IP[/E2], respectively) in endometrium collected at ovariectomy/hysterectomy on Day 16", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "oxytocin", "entity_1_idx": [[192, 200]], "entity_1_idx_in_text_with_entity_marker": [196, 204], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "IP", "entity_2_idx": [[255, 257]], "entity_2_idx_in_text_with_entity_marker": [268, 270], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d2.s3_IEPA.d2.s3.p0", "text": "These results indicate that oTP-1 may prevent luteolysis by inhibiting development of endometrial responsiveness to oxytocin and, therefore, reduce oxytocin-induced synthesis of IP3 and PGF2 alpha", "text_with_entity_marker": "These results indicate that oTP-1 may prevent luteolysis by inhibiting development of endometrial responsiveness to [E1]oxytocin[/E1] and, therefore, reduce [E2]oxytocin[/E2]-induced synthesis of IP3 and PGF2 alpha", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "oxytocin", "entity_1_idx": [[116, 124]], "entity_1_idx_in_text_with_entity_marker": [120, 128], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "oxytocin", "entity_2_idx": [[148, 156]], "entity_2_idx_in_text_with_entity_marker": [161, 169], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d4.s6_IEPA.d4.s6.p0", "text": "In contrast, the potencies of oxytocin to raise IP and [Ca2+]i were similar and independent of extracellular Ca2+, and could be suppressed by pertussis toxin and phorbol ester, but not by verapamil", "text_with_entity_marker": "In contrast, the potencies of [E1]oxytocin[/E1] to raise [E2]IP[/E2] and [Ca2+]i were similar and independent of extracellular Ca2+, and could be suppressed by pertussis toxin and phorbol ester, but not by verapamil", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "oxytocin", "entity_1_idx": [[30, 38]], "entity_1_idx_in_text_with_entity_marker": [34, 42], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "IP", "entity_2_idx": [[48, 50]], "entity_2_idx_in_text_with_entity_marker": [61, 63], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d6.s12_IEPA.d6.s12.p0", "text": "In the guinea pig myometrium prelabelled with myo-[2-3H]inositol, carbachol and oxytocin enhanced a concentration-dependent and rapid release of IP3 which preceded that of IP2 and IP1", "text_with_entity_marker": "In the guinea pig myometrium prelabelled with myo-[2-3H]inositol, carbachol and [E1]oxytocin[/E1] enhanced a concentration-dependent and rapid release of [E2]IP3[/E2] which preceded that of IP2 and IP1", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "oxytocin", "entity_1_idx": [[80, 88]], "entity_1_idx_in_text_with_entity_marker": [84, 92], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "IP3", "entity_2_idx": [[145, 148]], "entity_2_idx_in_text_with_entity_marker": [158, 161], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d8.s17_IEPA.d8.s17.p0", "text": "It is concluded that the primary action of PGF2 alpha in myometrial cells is to enhance Ca2+ influx, whereas oxytocin and ET-1 receptors are coupled to phospholipase C, generating IP3 and raising the intracellular concentration of free Ca2+ from intracellular as well as extracellular sources", "text_with_entity_marker": "It is concluded that the primary action of PGF2 alpha in myometrial cells is to enhance Ca2+ influx, whereas [E1]oxytocin[/E1] and ET-1 receptors are coupled to phospholipase C, generating [E2]IP3[/E2] and raising the intracellular concentration of free Ca2+ from intracellular as well as extracellular sources", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "oxytocin", "entity_1_idx": [[109, 117]], "entity_1_idx_in_text_with_entity_marker": [113, 121], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "IP3", "entity_2_idx": [[180, 183]], "entity_2_idx_in_text_with_entity_marker": [193, 196], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d17.s36_IEPA.d17.s36.p2", "text": "There was also a very significant increase of IP1 after the addition of 1000 mU hCG (p < 0.001) and IP1 and IP3 when 1000 mU hCG plus oxytocin were added (p < 0.001 and p < 0.01, respectively)", "text_with_entity_marker": "There was also a very significant increase of [E1]IP1[/E1] after the addition of 1000 mU hCG (p < 0.001) and IP1 and IP3 when 1000 mU hCG plus [E2]oxytocin[/E2] were added (p < 0.001 and p < 0.01, respectively)", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "IP1", "entity_1_idx": [[46, 49]], "entity_1_idx_in_text_with_entity_marker": [50, 53], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "oxytocin", "entity_2_idx": [[134, 142]], "entity_2_idx_in_text_with_entity_marker": [147, 155], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d20.s43_IEPA.d20.s43.p0", "text": "Endometrial IP3 was increased within 30 seconds after OT treatment and preceded the increase in PGF2 alpha release stimulated by OT", "text_with_entity_marker": "Endometrial [E1]IP3[/E1] was increased within 30 seconds after [E2]OT[/E2] treatment and preceded the increase in PGF2 alpha release stimulated by OT", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "IP3", "entity_1_idx": [[12, 15]], "entity_1_idx_in_text_with_entity_marker": [16, 19], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "OT", "entity_2_idx": [[54, 56]], "entity_2_idx_in_text_with_entity_marker": [67, 69], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d22.s46_IEPA.d22.s46.p0", "text": "Once the abnormally phosphorylated abnormal prion protein isoform agent is initiated, any stress event ensuing in adult life induces a nerve growth factor-mediated synthesis of normal cellular prion protein isoform that aggregates to abnormally phosphorylated abnormal prion protein isoform, thereby becoming 'infected'/transformed into the same; due to the vicious circle of positive feedback invoked by the blocking of a prion protein-specific kinase", "text_with_entity_marker": "Once the abnormally phosphorylated abnormal [E1]prion protein[/E1] isoform agent is initiated, any stress event ensuing in adult life induces a nerve growth factor-mediated synthesis of normal cellular [E2]prion protein[/E2] isoform that aggregates to abnormally phosphorylated abnormal prion protein isoform, thereby becoming 'infected'/transformed into the same; due to the vicious circle of positive feedback invoked by the blocking of a prion protein-specific kinase", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "prion protein", "entity_1_idx": [[44, 57]], "entity_1_idx_in_text_with_entity_marker": [48, 61], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "prion protein", "entity_2_idx": [[193, 206]], "entity_2_idx_in_text_with_entity_marker": [206, 219], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d24.s51_IEPA.d24.s51.p4", "text": "The oxytocin antagonist 1-deamino-2-D-Tyr-(OEt)-4-Thr-8-Orn-oxytocin administered ICV increased insulin levels itself and therefore the effect on oxytocin-induced insulin secretion was difficult to evaluate", "text_with_entity_marker": "The oxytocin antagonist 1-deamino-2-D-Tyr-(OEt)-4-Thr-8-Orn-oxytocin administered ICV increased [E1]insulin[/E1] levels itself and therefore the effect on oxytocin-induced [E2]insulin[/E2] secretion was difficult to evaluate", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "insulin", "entity_1_idx": [[96, 103]], "entity_1_idx_in_text_with_entity_marker": [100, 107], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "insulin", "entity_2_idx": [[163, 170]], "entity_2_idx_in_text_with_entity_marker": [176, 183], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d32.s66_IEPA.d32.s66.p0", "text": "Gamma-aminobutyric acid mediation of the inhibitory effect of nitric oxide on the arginine vasopressin and oxytocin responses to insulin-induced hypoglycemia", "text_with_entity_marker": "Gamma-aminobutyric acid mediation of the inhibitory effect of nitric oxide on the arginine vasopressin and [E1]oxytocin[/E1] responses to [E2]insulin[/E2]-induced hypoglycemia", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "oxytocin", "entity_1_idx": [[107, 115]], "entity_1_idx_in_text_with_entity_marker": [111, 119], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "insulin", "entity_2_idx": [[129, 136]], "entity_2_idx_in_text_with_entity_marker": [142, 149], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d33.s71_IEPA.d33.s71.p0", "text": "Correlation between the stimulatory effect of oxytocin on the formation of inositol phosphates and the oxytocin receptor level in the pregnant rabbit myometrium", "text_with_entity_marker": "Correlation between the stimulatory effect of [E1]oxytocin[/E1] on the formation of [E2]inositol phosphates[/E2] and the oxytocin receptor level in the pregnant rabbit myometrium", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "oxytocin", "entity_1_idx": [[46, 54]], "entity_1_idx_in_text_with_entity_marker": [50, 58], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "inositol phosphates", "entity_2_idx": [[75, 94]], "entity_2_idx_in_text_with_entity_marker": [88, 107], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d34.s83_IEPA.d34.s83.p0", "text": "At the periphery of the interscapular brown adipose tissue depot, unilocular, UCP-negative adipocytes (mean diameter: 41.55 microns) with white-type mitochondria were observed, and these cells were leptin-positive", "text_with_entity_marker": "At the periphery of the interscapular brown adipose tissue depot, unilocular, [E1]UCP[/E1]-negative adipocytes (mean diameter: 41.55 microns) with white-type mitochondria were observed, and these cells were [E2]leptin[/E2]-positive", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "UCP", "entity_1_idx": [[78, 81]], "entity_1_idx_in_text_with_entity_marker": [82, 85], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "leptin", "entity_2_idx": [[198, 204]], "entity_2_idx_in_text_with_entity_marker": [211, 217], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d34.s85_IEPA.d34.s85.p0", "text": "In summary, classical brown adipocytes differ from white adipocytes, not only by their morphology and UCP expression, but also by their apparent lack of detectable leptin expression", "text_with_entity_marker": "In summary, classical brown adipocytes differ from white adipocytes, not only by their morphology and [E1]UCP[/E1] expression, but also by their apparent lack of detectable [E2]leptin[/E2] expression", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "UCP", "entity_1_idx": [[102, 105]], "entity_1_idx_in_text_with_entity_marker": [106, 109], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "leptin", "entity_2_idx": [[164, 170]], "entity_2_idx_in_text_with_entity_marker": [177, 183], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d39.s95_IEPA.d39.s95.p2", "text": "Both p-nitrophenylphosphatidylcholine hydrolytic activity and liposome lytic activity of insulin-phospholipase C conjugate were inhibited in the presence of insulin antiserum", "text_with_entity_marker": "Both p-nitrophenylphosphatidylcholine hydrolytic activity and liposome lytic activity of insulin-[E1]phospholipase C[/E1] conjugate were inhibited in the presence of [E2]insulin[/E2] antiserum", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "phospholipase C", "entity_1_idx": [[97, 112]], "entity_1_idx_in_text_with_entity_marker": [101, 116], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "insulin", "entity_2_idx": [[157, 164]], "entity_2_idx_in_text_with_entity_marker": [170, 177], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d41.s100_IEPA.d41.s100.p0", "text": "Regulation of insulin secretion via ATP-sensitive K+ channel independent mechanisms: role of phospholipase C", "text_with_entity_marker": "Regulation of [E1]insulin[/E1] secretion via ATP-sensitive K+ channel independent mechanisms: role of [E2]phospholipase C[/E2]", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "insulin", "entity_1_idx": [[14, 21]], "entity_1_idx_in_text_with_entity_marker": [18, 25], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "phospholipase C", "entity_2_idx": [[93, 108]], "entity_2_idx_in_text_with_entity_marker": [106, 121], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d44.s113_IEPA.d44.s113.p0", "text": "The data obtained suggest (i) that selective oxytocin receptors are present on the membranes of guinea-pig antral smooth muscle cells, (ii) that the oxytocin-related relaxation may result from the activation of Ca(2+)-sensitive K+ conductivity via activation of IP3-induced release of Ca2+ from the submembrane located cisternae of the sarcoplasmic reticulum Ca2+ stores and (iii) in turn, this evokes a non-inactivating component of IK, hyperpolarizing the cell membrane", "text_with_entity_marker": "The data obtained suggest (i) that selective [E1]oxytocin[/E1] receptors are present on the membranes of guinea-pig antral smooth muscle cells, (ii) that the oxytocin-related relaxation may result from the activation of Ca(2+)-sensitive K+ conductivity via activation of [E2]IP3[/E2]-induced release of Ca2+ from the submembrane located cisternae of the sarcoplasmic reticulum Ca2+ stores and (iii) in turn, this evokes a non-inactivating component of IK, hyperpolarizing the cell membrane", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "oxytocin", "entity_1_idx": [[45, 53]], "entity_1_idx_in_text_with_entity_marker": [49, 57], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "IP3", "entity_2_idx": [[262, 265]], "entity_2_idx_in_text_with_entity_marker": [275, 278], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d48.s123_IEPA.d48.s123.p0", "text": "Leptin increases uncoupling protein expression and energy expenditure", "text_with_entity_marker": "[E1]Leptin[/E1] increases [E2]uncoupling protein[/E2] expression and energy expenditure", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "Leptin", "entity_1_idx": [[0, 6]], "entity_1_idx_in_text_with_entity_marker": [4, 10], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "uncoupling protein", "entity_2_idx": [[17, 35]], "entity_2_idx_in_text_with_entity_marker": [30, 48], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d51.s133_IEPA.d51.s133.p0", "text": "Insulin stimulates the release of the glycosyl phosphatidylinositol-anchored membrane dipeptidase from 3T3-L1 adipocytes through the action of a phospholipase C", "text_with_entity_marker": "[E1]Insulin[/E1] stimulates the release of the glycosyl phosphatidylinositol-anchored membrane dipeptidase from 3T3-L1 adipocytes through the action of a [E2]phospholipase C[/E2]", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "Insulin", "entity_1_idx": [[0, 7]], "entity_1_idx_in_text_with_entity_marker": [4, 11], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "phospholipase C", "entity_2_idx": [[145, 160]], "entity_2_idx_in_text_with_entity_marker": [158, 173], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d52.s136_IEPA.d52.s136.p0", "text": "UCP3 mRNA levels were also regulated by dexamethasone, leptin, and starvation, albeit differently in muscle and brown adipose tissue", "text_with_entity_marker": "[E1]UCP3[/E1] mRNA levels were also regulated by dexamethasone, [E2]leptin[/E2], and starvation, albeit differently in muscle and brown adipose tissue", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "UCP3", "entity_1_idx": [[0, 4]], "entity_1_idx_in_text_with_entity_marker": [4, 8], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "leptin", "entity_2_idx": [[55, 61]], "entity_2_idx_in_text_with_entity_marker": [68, 74], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d54.s138_IEPA.d54.s138.p0", "text": "This effect is maximal at 10(-8) M AVP (a concentration clearly above the normal physiological range of AVP concentrations) and involves the V2 receptor pathway, while activation of protein kinase C or changes in intracellular calcium are ineffective", "text_with_entity_marker": "This effect is maximal at 10(-8) M [E1]AVP[/E1] (a concentration clearly above the normal physiological range of [E2]AVP[/E2] concentrations) and involves the V2 receptor pathway, while activation of protein kinase C or changes in intracellular calcium are ineffective", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "AVP", "entity_1_idx": [[35, 38]], "entity_1_idx_in_text_with_entity_marker": [39, 42], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "AVP", "entity_2_idx": [[104, 107]], "entity_2_idx_in_text_with_entity_marker": [117, 120], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d56.s143_IEPA.d56.s143.p0", "text": "Interleukin-1 beta inhibits phospholipase C and insulin secretion at sites apart from KATP channel", "text_with_entity_marker": "Interleukin-1 beta inhibits [E1]phospholipase C[/E1] and [E2]insulin[/E2] secretion at sites apart from KATP channel", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "phospholipase C", "entity_1_idx": [[28, 43]], "entity_1_idx_in_text_with_entity_marker": [32, 47], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "insulin", "entity_2_idx": [[48, 55]], "entity_2_idx_in_text_with_entity_marker": [61, 68], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d56.s145_IEPA.d56.s145.p0", "text": "These data (together with the finding that IL-1 beta inhibited Ca(2+)-induced insulin release) suggest that, in addition to its effects on ATP synthesis and thereby on the KATP channel, IL-1 beta has at least two undescribed, distal effects to block both PLC as well as Ca(2+)-induced exocytosis", "text_with_entity_marker": "These data (together with the finding that IL-1 beta inhibited Ca(2+)-induced [E1]insulin[/E1] release) suggest that, in addition to its effects on ATP synthesis and thereby on the KATP channel, IL-1 beta has at least two undescribed, distal effects to block both [E2]PLC[/E2] as well as Ca(2+)-induced exocytosis", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "insulin", "entity_1_idx": [[78, 85]], "entity_1_idx_in_text_with_entity_marker": [82, 89], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "PLC", "entity_2_idx": [[255, 258]], "entity_2_idx_in_text_with_entity_marker": [268, 271], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d57.s147_IEPA.d57.s147.p2", "text": "Despite the low levels of insulin-induced PLC activity, insulin-stimulated glucose transport activity was similarly inhibited by U73122 (55.9 +/- 13.1% inhibition)", "text_with_entity_marker": "Despite the low levels of insulin-induced [E1]PLC[/E1] activity, [E2]insulin[/E2]-stimulated glucose transport activity was similarly inhibited by U73122 (55.9 +/- 13.1% inhibition)", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "PLC", "entity_1_idx": [[42, 45]], "entity_1_idx_in_text_with_entity_marker": [46, 49], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "insulin", "entity_2_idx": [[56, 63]], "entity_2_idx_in_text_with_entity_marker": [69, 76], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d58.s151_IEPA.d58.s151.p2", "text": "In these cells, AVP also causes the translocation of PKC from the cytosol to the cell membrane which is maximal at 5 min, but the intracellular events distal to protein kinase C activation that underlie ACTH secretion have not been well characterized to date", "text_with_entity_marker": "In these cells, AVP also causes the translocation of [E1]PKC[/E1] from the cytosol to the cell membrane which is maximal at 5 min, but the intracellular events distal to [E2]protein kinase C[/E2] activation that underlie ACTH secretion have not been well characterized to date", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "PKC", "entity_1_idx": [[53, 56]], "entity_1_idx_in_text_with_entity_marker": [57, 60], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "protein kinase C", "entity_2_idx": [[161, 177]], "entity_2_idx_in_text_with_entity_marker": [174, 190], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d58.s152_IEPA.d58.s152.p0", "text": "Since the MARCKS protein has been implicated in neurosecretion and is phosphorylated by PKC in synaptosomes, studies were carried out to determine whether AVP might cause MARCKS phosphorylation in the ovine anterior pituitary, and to determine whether this phenomenon might be temporally correlated with PKC translocation and the release of ACTH", "text_with_entity_marker": "Since the MARCKS protein has been implicated in neurosecretion and is phosphorylated by [E1]PKC[/E1] in synaptosomes, studies were carried out to determine whether [E2]AVP[/E2] might cause MARCKS phosphorylation in the ovine anterior pituitary, and to determine whether this phenomenon might be temporally correlated with PKC translocation and the release of ACTH", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "PKC", "entity_1_idx": [[88, 91]], "entity_1_idx_in_text_with_entity_marker": [92, 95], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "AVP", "entity_2_idx": [[155, 158]], "entity_2_idx_in_text_with_entity_marker": [168, 171], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d67.s168_IEPA.d67.s168.p2", "text": "To determine the functional significance of the interaction of PLCgamma and the IR, we used a specific inhibitor of PLC, U73122, or microinjection of SH2 domain glutathione S-transferase fusion proteins derived from PLCgamma to block insulin-stimulated GLUT4 translocation", "text_with_entity_marker": "To determine the functional significance of the interaction of [E1]PLCgamma[/E1] and the IR, we used a specific inhibitor of PLC, U73122, or microinjection of SH2 domain glutathione S-transferase fusion proteins derived from PLCgamma to block [E2]insulin[/E2]-stimulated GLUT4 translocation", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "PLCgamma", "entity_1_idx": [[63, 71]], "entity_1_idx_in_text_with_entity_marker": [67, 75], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "insulin", "entity_2_idx": [[234, 241]], "entity_2_idx_in_text_with_entity_marker": [247, 254], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d73.s175_IEPA.d73.s175.p0", "text": "Strikingly, in adipocytes subjected to combined trypsin/salt treatment, PIG-P, PI-specific PLC, and glimepiride failed completely to provoke insulin-mimetic effects", "text_with_entity_marker": "Strikingly, in adipocytes subjected to combined trypsin/salt treatment, PIG-P, PI-specific [E1]PLC[/E1], and glimepiride failed completely to provoke [E2]insulin[/E2]-mimetic effects", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "PLC", "entity_1_idx": [[91, 94]], "entity_1_idx_in_text_with_entity_marker": [95, 98], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "insulin", "entity_2_idx": [[141, 148]], "entity_2_idx_in_text_with_entity_marker": [154, 161], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d74.s178_IEPA.d74.s178.p2", "text": "While leptin maintains or favors energy-dissipating mechanisms (UCP1, UCP2, and UCP3), the latter are markedly depressed in pair-fed rats", "text_with_entity_marker": "While [E1]leptin[/E1] maintains or favors energy-dissipating mechanisms (UCP1, UCP2, and [E2]UCP3[/E2]), the latter are markedly depressed in pair-fed rats", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "leptin", "entity_1_idx": [[6, 12]], "entity_1_idx_in_text_with_entity_marker": [10, 16], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "UCP3", "entity_2_idx": [[80, 84]], "entity_2_idx_in_text_with_entity_marker": [93, 97], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d77.s185_IEPA.d77.s185.p0", "text": "Although osmotic stimuli cause an increase in nitric oxide synthase (NOS) activity as well as synthesis of AVP and oxytocin in the paraventricular (PVN) and supraoptic nuclei (SON), it is not known whether NOS activity in the hypothalamus changes in the diabetic patients who have plasma hyperosmolality with hyperglycaemia caused by insulin deficiency", "text_with_entity_marker": "Although osmotic stimuli cause an increase in nitric oxide synthase (NOS) activity as well as synthesis of AVP and [E1]oxytocin[/E1] in the paraventricular (PVN) and supraoptic nuclei (SON), it is not known whether NOS activity in the hypothalamus changes in the diabetic patients who have plasma hyperosmolality with hyperglycaemia caused by [E2]insulin[/E2] deficiency", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "oxytocin", "entity_1_idx": [[115, 123]], "entity_1_idx_in_text_with_entity_marker": [119, 127], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "insulin", "entity_2_idx": [[334, 341]], "entity_2_idx_in_text_with_entity_marker": [347, 354], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d80.s190_IEPA.d80.s190.p0", "text": "To explore the possible roles of the hypothalamic melanocortin system in leptin action, we examined the effects of intracerebroventricular (i.c.v.) injection of leptin with or without SHU9119, a potent antagonist of alpha-melanocyte stimulating hormone, on food intake, body weight, and mitochondrial uncoupling protein-1 (UCP-1) mRNA expression in the brown adipose tissue (BAT) in rats", "text_with_entity_marker": "To explore the possible roles of the hypothalamic melanocortin system in [E1]leptin[/E1] action, we examined the effects of intracerebroventricular (i.c.v.) injection of [E2]leptin[/E2] with or without SHU9119, a potent antagonist of alpha-melanocyte stimulating hormone, on food intake, body weight, and mitochondrial uncoupling protein-1 (UCP-1) mRNA expression in the brown adipose tissue (BAT) in rats", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "leptin", "entity_1_idx": [[73, 79]], "entity_1_idx_in_text_with_entity_marker": [77, 83], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "leptin", "entity_2_idx": [[161, 167]], "entity_2_idx_in_text_with_entity_marker": [174, 180], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d80.s190_IEPA.d80.s190.p2", "text": "To explore the possible roles of the hypothalamic melanocortin system in leptin action, we examined the effects of intracerebroventricular (i.c.v.) injection of leptin with or without SHU9119, a potent antagonist of alpha-melanocyte stimulating hormone, on food intake, body weight, and mitochondrial uncoupling protein-1 (UCP-1) mRNA expression in the brown adipose tissue (BAT) in rats", "text_with_entity_marker": "To explore the possible roles of the hypothalamic melanocortin system in leptin action, we examined the effects of intracerebroventricular (i.c.v.) injection of [E1]leptin[/E1] with or without SHU9119, a potent antagonist of alpha-melanocyte stimulating hormone, on food intake, body weight, and mitochondrial [E2]uncoupling protein-1[/E2] (UCP-1) mRNA expression in the brown adipose tissue (BAT) in rats", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "leptin", "entity_1_idx": [[161, 167]], "entity_1_idx_in_text_with_entity_marker": [165, 171], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "uncoupling protein-1", "entity_2_idx": [[301, 321]], "entity_2_idx_in_text_with_entity_marker": [314, 334], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d81.s194_IEPA.d81.s194.p0", "text": "(-)Nicotine did not blunt the AbetaP activation of phospholipase C", "text_with_entity_marker": "(-)Nicotine did not blunt the [E1]AbetaP[/E1] activation of [E2]phospholipase C[/E2]", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "AbetaP", "entity_1_idx": [[30, 36]], "entity_1_idx_in_text_with_entity_marker": [34, 40], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "phospholipase C", "entity_2_idx": [[51, 66]], "entity_2_idx_in_text_with_entity_marker": [64, 79], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d88.s207_IEPA.d88.s207.p7", "text": "To elucidate the pathophysiologic significance of UCP3 and UCP2 in the effect of TZDs on glucose metabolism and energy expenditure, we examined their basal mRNA levels in the WAT, brown adipose tissue (BAT), and skeletal muscle from Wistar fatty rats, a rat model of NIDDM and obesity with leptin receptor defect, and investigated expression of the genes encoding UCP3 and UCP2 in Wistar fatty rats and in Wistar lean rats with 2-week oral administration of 3 mg x kg(-1) x day(-1) pioglitazone, a TZD derivative", "text_with_entity_marker": "To elucidate the pathophysiologic significance of UCP3 and UCP2 in the effect of TZDs on glucose metabolism and energy expenditure, we examined their basal mRNA levels in the WAT, brown adipose tissue (BAT), and skeletal muscle from Wistar fatty rats, a rat model of NIDDM and obesity with [E1]leptin[/E1] receptor defect, and investigated expression of the genes encoding [E2]UCP3[/E2] and UCP2 in Wistar fatty rats and in Wistar lean rats with 2-week oral administration of 3 mg x kg(-1) x day(-1) pioglitazone, a TZD derivative", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "leptin", "entity_1_idx": [[290, 296]], "entity_1_idx_in_text_with_entity_marker": [294, 300], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "UCP3", "entity_2_idx": [[364, 368]], "entity_2_idx_in_text_with_entity_marker": [377, 381], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d89.s209_IEPA.d89.s209.p0", "text": "UCP2, UCP3 and leptin gene expression: modulation by food restriction and leptin", "text_with_entity_marker": "[E1]UCP2[/E1], [E2]UCP3[/E2] and leptin gene expression: modulation by food restriction and leptin", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "UCP2", "entity_1_idx": [[0, 4]], "entity_1_idx_in_text_with_entity_marker": [4, 8], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "UCP3", "entity_2_idx": [[6, 10]], "entity_2_idx_in_text_with_entity_marker": [19, 23], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d89.s210_IEPA.d89.s210.p0", "text": "To determine the effects of food restriction and leptin administration on several transcripts involved in energy homeostasis, we examined leptin, uncoupling proteins (UCP) 1, 2 and 3, lipoprotein lipase (LPL), beta3-adrenergic receptors (beta3AR) and hormone-sensitive lipase (HSL) mRNA levels in brown adipose tissue (BAT) and epididymal (EWAT) and perirenal (PWAT) white adipose tissue in three groups of rats", "text_with_entity_marker": "To determine the effects of food restriction and [E1]leptin[/E1] administration on several transcripts involved in energy homeostasis, we examined [E2]leptin[/E2], uncoupling proteins (UCP) 1, 2 and 3, lipoprotein lipase (LPL), beta3-adrenergic receptors (beta3AR) and hormone-sensitive lipase (HSL) mRNA levels in brown adipose tissue (BAT) and epididymal (EWAT) and perirenal (PWAT) white adipose tissue in three groups of rats", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "leptin", "entity_1_idx": [[49, 55]], "entity_1_idx_in_text_with_entity_marker": [53, 59], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "leptin", "entity_2_idx": [[138, 144]], "entity_2_idx_in_text_with_entity_marker": [151, 157], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d89.s211_IEPA.d89.s211.p1", "text": "Leptin increased LPL mRNA by 80%, UCP1 mRNA twofold, and UCP3 mRNA levels by 62% in BAT, and increased UCP2 mRNA levels twofold in EWAT", "text_with_entity_marker": "[E1]Leptin[/E1] increased LPL mRNA by 80%, UCP1 mRNA twofold, and [E2]UCP3[/E2] mRNA levels by 62% in BAT, and increased UCP2 mRNA levels twofold in EWAT", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "Leptin", "entity_1_idx": [[0, 6]], "entity_1_idx_in_text_with_entity_marker": [4, 10], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "UCP3", "entity_2_idx": [[57, 61]], "entity_2_idx_in_text_with_entity_marker": [70, 74], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d89.s211_IEPA.d89.s211.p3", "text": "Leptin increased LPL mRNA by 80%, UCP1 mRNA twofold, and UCP3 mRNA levels by 62% in BAT, and increased UCP2 mRNA levels twofold in EWAT", "text_with_entity_marker": "Leptin increased LPL mRNA by 80%, [E1]UCP1[/E1] mRNA twofold, and [E2]UCP3[/E2] mRNA levels by 62% in BAT, and increased UCP2 mRNA levels twofold in EWAT", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "UCP1", "entity_1_idx": [[34, 38]], "entity_1_idx_in_text_with_entity_marker": [38, 42], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "UCP3", "entity_2_idx": [[57, 61]], "entity_2_idx_in_text_with_entity_marker": [70, 74], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d89.s212_IEPA.d89.s212.p2", "text": "The present study indicates that leptin increases the gene expression of UCP2 in EWAT and that of UCP1, UCP3 and LPL in BAT, whereas reduced food consumption but not leptin, decreases LPL expression in WAT", "text_with_entity_marker": "The present study indicates that [E1]leptin[/E1] increases the gene expression of UCP2 in EWAT and that of UCP1, [E2]UCP3[/E2] and LPL in BAT, whereas reduced food consumption but not leptin, decreases LPL expression in WAT", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "leptin", "entity_1_idx": [[33, 39]], "entity_1_idx_in_text_with_entity_marker": [37, 43], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "UCP3", "entity_2_idx": [[104, 108]], "entity_2_idx_in_text_with_entity_marker": [117, 121], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d91.s223_IEPA.d91.s223.p2", "text": "U-73122 at 8 mumol.L-1 totally abolished the Oxy-induced increases in [Ca2+]i and IP3; however it reduced the Oxy-induced increase in insulin release only by 36% and 63% in the monolayer and suspended cell preparations, respectively", "text_with_entity_marker": "U-73122 at 8 mumol.L-1 totally abolished the Oxy-induced increases in [Ca2+]i and IP3; however it reduced the [E1]Oxy[/E1]-induced increase in [E2]insulin[/E2] release only by 36% and 63% in the monolayer and suspended cell preparations, respectively", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "Oxy", "entity_1_idx": [[110, 113]], "entity_1_idx_in_text_with_entity_marker": [114, 117], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "insulin", "entity_2_idx": [[134, 141]], "entity_2_idx_in_text_with_entity_marker": [147, 154], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d92.s225_IEPA.d92.s225.p0", "text": "In isolated adipocytes, the loss of almost half the 18S RNA content over a 24-hour incubation was prevented in the presence of insulin but not oxytocin or epidermal growth factor (EGF)", "text_with_entity_marker": "In isolated adipocytes, the loss of almost half the 18S RNA content over a 24-hour incubation was prevented in the presence of [E1]insulin[/E1] but not [E2]oxytocin[/E2] or epidermal growth factor (EGF)", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "insulin", "entity_1_idx": [[127, 134]], "entity_1_idx_in_text_with_entity_marker": [131, 138], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "oxytocin", "entity_2_idx": [[143, 151]], "entity_2_idx_in_text_with_entity_marker": [156, 164], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d94.s228_IEPA.d94.s228.p0", "text": "Thus, OT was proposed to be the self antigen of the neurohypophysial family, and IGF-2 the self antigen precursor of the insulin family", "text_with_entity_marker": "Thus, [E1]OT[/E1] was proposed to be the self antigen of the neurohypophysial family, and IGF-2 the self antigen precursor of the [E2]insulin[/E2] family", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "OT", "entity_1_idx": [[6, 8]], "entity_1_idx_in_text_with_entity_marker": [10, 12], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "insulin", "entity_2_idx": [[121, 128]], "entity_2_idx_in_text_with_entity_marker": [134, 141], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d95.s229_IEPA.d95.s229.p0", "text": "The distribution of arginine-vasopressin (AVP) cells in the SCN overlapped with that of PKC in both species", "text_with_entity_marker": "The distribution of [E1]arginine-vasopressin[/E1] (AVP) cells in the SCN overlapped with that of [E2]PKC[/E2] in both species", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "arginine-vasopressin", "entity_1_idx": [[20, 40]], "entity_1_idx_in_text_with_entity_marker": [24, 44], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "PKC", "entity_2_idx": [[88, 91]], "entity_2_idx_in_text_with_entity_marker": [101, 104], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d96.s233_IEPA.d96.s233.p1", "text": "Denervation suppressed mRNA levels for UCP-2 (49%), UCP-3 (36%), and COX-IV (59%) and eliminated the acute response to leptin in SM", "text_with_entity_marker": "Denervation suppressed mRNA levels for [E1]UCP-2[/E1] (49%), UCP-3 (36%), and COX-IV (59%) and eliminated the acute response to [E2]leptin[/E2] in SM", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "UCP-2", "entity_1_idx": [[39, 44]], "entity_1_idx_in_text_with_entity_marker": [43, 48], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "leptin", "entity_2_idx": [[119, 125]], "entity_2_idx_in_text_with_entity_marker": [132, 138], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d101.s240_IEPA.d101.s240.p0", "text": "The two groups were similar in their morning thyroxin, triiodothyronine, TSH, estradiol, cortisol, gastrin, cholecystokinin, somatostatin, oxytocin, insulin and IGF-1 levels", "text_with_entity_marker": "The two groups were similar in their morning thyroxin, triiodothyronine, TSH, estradiol, cortisol, gastrin, cholecystokinin, somatostatin, [E1]oxytocin[/E1], [E2]insulin[/E2] and IGF-1 levels", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "oxytocin", "entity_1_idx": [[139, 147]], "entity_1_idx_in_text_with_entity_marker": [143, 151], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "insulin", "entity_2_idx": [[149, 156]], "entity_2_idx_in_text_with_entity_marker": [162, 169], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d107.s249_IEPA.d107.s249.p0", "text": "To further understand the possible role of protein phosphatases 1 and 2A in the GA-dependent expression of Osamy-c, we isolated cDNA clones encoding protein phosphatase 1 and protein phosphatase 2A from a rice aleurone cDNA library", "text_with_entity_marker": "To further understand the possible role of protein phosphatases 1 and 2A in the [E1]GA[/E1]-dependent expression of [E2]Osamy-c[/E2], we isolated cDNA clones encoding protein phosphatase 1 and protein phosphatase 2A from a rice aleurone cDNA library", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "GA", "entity_1_idx": [[80, 82]], "entity_1_idx_in_text_with_entity_marker": [84, 86], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "Osamy-c", "entity_2_idx": [[107, 114]], "entity_2_idx_in_text_with_entity_marker": [120, 127], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d109.s261_IEPA.d109.s261.p0", "text": "Fasting, with or without leptin administration, did not affect BAT UCP-2 mRNA; however, leptin administration to ad libitum fed rats significantly increased BAT UCP-2 mRNA, to 138% of control", "text_with_entity_marker": "Fasting, with or without [E1]leptin[/E1] administration, did not affect BAT [E2]UCP-2[/E2] mRNA; however, leptin administration to ad libitum fed rats significantly increased BAT UCP-2 mRNA, to 138% of control", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "leptin", "entity_1_idx": [[25, 31]], "entity_1_idx_in_text_with_entity_marker": [29, 35], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "UCP-2", "entity_2_idx": [[67, 72]], "entity_2_idx_in_text_with_entity_marker": [80, 85], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d109.s262_IEPA.d109.s262.p0", "text": "Fasting significantly enhanced gastrocnemius muscle UCP-3 mRNA (411% of control) and protein expression (168% of control), whereas leptin administration to fasted rats did not alter either of these effects", "text_with_entity_marker": "Fasting significantly enhanced gastrocnemius muscle [E1]UCP-3[/E1] mRNA (411% of control) and protein expression (168% of control), whereas [E2]leptin[/E2] administration to fasted rats did not alter either of these effects", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "UCP-3", "entity_1_idx": [[52, 57]], "entity_1_idx_in_text_with_entity_marker": [56, 61], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "leptin", "entity_2_idx": [[131, 137]], "entity_2_idx_in_text_with_entity_marker": [144, 150], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d113.s272_IEPA.d113.s272.p0", "text": "The experiments were concluded by taking blood samples for later analysis of plasma glucose and plasma levels of the following hormones: insulin, gastrin, CCK, glucagon, somatostatin, oxytocin and corticosterone", "text_with_entity_marker": "The experiments were concluded by taking blood samples for later analysis of plasma glucose and plasma levels of the following hormones: [E1]insulin[/E1], gastrin, CCK, glucagon, somatostatin, [E2]oxytocin[/E2] and corticosterone", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "insulin", "entity_1_idx": [[137, 144]], "entity_1_idx_in_text_with_entity_marker": [141, 148], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "oxytocin", "entity_2_idx": [[184, 192]], "entity_2_idx_in_text_with_entity_marker": [197, 205], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d115.s277_IEPA.d115.s277.p0", "text": "Overexpression of G11alpha and isoforms of phospholipase C in islet  beta-cells reveals a lack of correlation between inositol phosphate  accumulation and insulin secretion.", "text_with_entity_marker": "Overexpression of G11alpha and isoforms of [E1]phospholipase C[/E1] in islet  beta-cells reveals a lack of correlation between inositol phosphate  accumulation and [E2]insulin[/E2] secretion.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "phospholipase C", "entity_1_idx": [[43, 58]], "entity_1_idx_in_text_with_entity_marker": [47, 62], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "insulin", "entity_2_idx": [[155, 162]], "entity_2_idx_in_text_with_entity_marker": [168, 175], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d115.s283_IEPA.d115.s283.p0", "text": "Overexpression of G11alpha enhances IP accumulation, an effect  slightly potentiated by co-overexpression of PLC-beta1 or -beta3, but  these maneuvers do not affect glucose or carbachol-stimulated insulin  secretion.", "text_with_entity_marker": "Overexpression of G11alpha enhances IP accumulation, an effect  slightly potentiated by co-overexpression of [E1]PLC[/E1]-beta1 or -beta3, but  these maneuvers do not affect glucose or carbachol-stimulated [E2]insulin[/E2]  secretion.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "PLC", "entity_1_idx": [[109, 112]], "entity_1_idx_in_text_with_entity_marker": [113, 116], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "insulin", "entity_2_idx": [[197, 204]], "entity_2_idx_in_text_with_entity_marker": [210, 217], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d122.s294_IEPA.d122.s294.p8", "text": "Relative UCP expression levels were 100, 104, and 33 for UCP1, 100, 191, and 125 for UCP2 and 100, 107, and 29 for UCP3 in ad libitum fed control rats, in leptin-treated rats and in pair-fed control rats, respectively", "text_with_entity_marker": "Relative UCP expression levels were 100, 104, and 33 for UCP1, 100, 191, and 125 for [E1]UCP2[/E1] and 100, 107, and 29 for UCP3 in ad libitum fed control rats, in [E2]leptin[/E2]-treated rats and in pair-fed control rats, respectively", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "UCP2", "entity_1_idx": [[85, 89]], "entity_1_idx_in_text_with_entity_marker": [89, 93], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "leptin", "entity_2_idx": [[155, 161]], "entity_2_idx_in_text_with_entity_marker": [168, 174], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d122.s294_IEPA.d122.s294.p9", "text": "Relative UCP expression levels were 100, 104, and 33 for UCP1, 100, 191, and 125 for UCP2 and 100, 107, and 29 for UCP3 in ad libitum fed control rats, in leptin-treated rats and in pair-fed control rats, respectively", "text_with_entity_marker": "Relative UCP expression levels were 100, 104, and 33 for UCP1, 100, 191, and 125 for UCP2 and 100, 107, and 29 for [E1]UCP3[/E1] in ad libitum fed control rats, in [E2]leptin[/E2]-treated rats and in pair-fed control rats, respectively", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "UCP3", "entity_1_idx": [[115, 119]], "entity_1_idx_in_text_with_entity_marker": [119, 123], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "leptin", "entity_2_idx": [[155, 161]], "entity_2_idx_in_text_with_entity_marker": [168, 174], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d126.s299_IEPA.d126.s299.p3", "text": "The expression of uterine UCP2 and UCP3 were up-regulated by 3.2- and 1.5-fold, respectively, during the late stage of pregnancy with an increase of WAT leptin mRNA expression and exogenous administration of leptin resulted in induction of the uterine UCP2 and UCP3 levels", "text_with_entity_marker": "The expression of uterine [E1]UCP2[/E1] and UCP3 were up-regulated by 3.2- and 1.5-fold, respectively, during the late stage of pregnancy with an increase of WAT leptin mRNA expression and exogenous administration of leptin resulted in induction of the uterine [E2]UCP2[/E2] and UCP3 levels", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "UCP2", "entity_1_idx": [[26, 30]], "entity_1_idx_in_text_with_entity_marker": [30, 34], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "UCP2", "entity_2_idx": [[252, 256]], "entity_2_idx_in_text_with_entity_marker": [265, 269], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d126.s299_IEPA.d126.s299.p4", "text": "The expression of uterine UCP2 and UCP3 were up-regulated by 3.2- and 1.5-fold, respectively, during the late stage of pregnancy with an increase of WAT leptin mRNA expression and exogenous administration of leptin resulted in induction of the uterine UCP2 and UCP3 levels", "text_with_entity_marker": "The expression of uterine [E1]UCP2[/E1] and UCP3 were up-regulated by 3.2- and 1.5-fold, respectively, during the late stage of pregnancy with an increase of WAT leptin mRNA expression and exogenous administration of leptin resulted in induction of the uterine UCP2 and [E2]UCP3[/E2] levels", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "UCP2", "entity_1_idx": [[26, 30]], "entity_1_idx_in_text_with_entity_marker": [30, 34], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "UCP3", "entity_2_idx": [[261, 265]], "entity_2_idx_in_text_with_entity_marker": [274, 278], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d126.s299_IEPA.d126.s299.p10", "text": "The expression of uterine UCP2 and UCP3 were up-regulated by 3.2- and 1.5-fold, respectively, during the late stage of pregnancy with an increase of WAT leptin mRNA expression and exogenous administration of leptin resulted in induction of the uterine UCP2 and UCP3 levels", "text_with_entity_marker": "The expression of uterine UCP2 and UCP3 were up-regulated by 3.2- and 1.5-fold, respectively, during the late stage of pregnancy with an increase of WAT [E1]leptin[/E1] mRNA expression and exogenous administration of leptin resulted in induction of the uterine [E2]UCP2[/E2] and UCP3 levels", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "leptin", "entity_1_idx": [[153, 159]], "entity_1_idx_in_text_with_entity_marker": [157, 163], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "UCP2", "entity_2_idx": [[252, 256]], "entity_2_idx_in_text_with_entity_marker": [265, 269], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d126.s299_IEPA.d126.s299.p13", "text": "The expression of uterine UCP2 and UCP3 were up-regulated by 3.2- and 1.5-fold, respectively, during the late stage of pregnancy with an increase of WAT leptin mRNA expression and exogenous administration of leptin resulted in induction of the uterine UCP2 and UCP3 levels", "text_with_entity_marker": "The expression of uterine UCP2 and UCP3 were up-regulated by 3.2- and 1.5-fold, respectively, during the late stage of pregnancy with an increase of WAT leptin mRNA expression and exogenous administration of [E1]leptin[/E1] resulted in induction of the uterine UCP2 and [E2]UCP3[/E2] levels", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "leptin", "entity_1_idx": [[208, 214]], "entity_1_idx_in_text_with_entity_marker": [212, 218], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "UCP3", "entity_2_idx": [[261, 265]], "entity_2_idx_in_text_with_entity_marker": [274, 278], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d129.s309_IEPA.d129.s309.p2", "text": "We examined plasma leptin, leptin mRNA, and adipose and muscle UCP subtype mRNA in rats treated with alpha-methyl-p-tyrosine methyl ester (AMPT-ME), which inhibits catecholamine synthesis and 6-hydroxydopamine (6HDA), which is toxic to catecholinergic nerve terminals but, unlike AMPT-ME, does not enter the central nervous system", "text_with_entity_marker": "We examined plasma [E1]leptin[/E1], leptin mRNA, and adipose and muscle [E2]UCP[/E2] subtype mRNA in rats treated with alpha-methyl-p-tyrosine methyl ester (AMPT-ME), which inhibits catecholamine synthesis and 6-hydroxydopamine (6HDA), which is toxic to catecholinergic nerve terminals but, unlike AMPT-ME, does not enter the central nervous system", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "leptin", "entity_1_idx": [[19, 25]], "entity_1_idx_in_text_with_entity_marker": [23, 29], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "UCP", "entity_2_idx": [[63, 66]], "entity_2_idx_in_text_with_entity_marker": [76, 79], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d129.s310_IEPA.d129.s310.p2", "text": "Intraperitoneal 6HDA, 100 mg/kg, as a single dose at 1800, increased plasma leptin approximately twofold after 18-20 h, increased IBAT (but not epididymal fat) leptin mRNA by two- to threefold, and decreased IBAT UCP-3 mRNA to 30-40% of control", "text_with_entity_marker": "Intraperitoneal 6HDA, 100 mg/kg, as a single dose at 1800, increased plasma leptin approximately twofold after 18-20 h, increased IBAT (but not epididymal fat) [E1]leptin[/E1] mRNA by two- to threefold, and decreased IBAT [E2]UCP-3[/E2] mRNA to 30-40% of control", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "leptin", "entity_1_idx": [[160, 166]], "entity_1_idx_in_text_with_entity_marker": [164, 170], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "UCP-3", "entity_2_idx": [[213, 218]], "entity_2_idx_in_text_with_entity_marker": [226, 231], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d130.s314_IEPA.d130.s314.p4", "text": "Moreover, A beta 25-35 had no effect on basal PIP2-PLC activity and cytosolic PI-PLC and PIP2-PLC", "text_with_entity_marker": "Moreover, A beta 25-35 had no effect on basal [E1]PIP2-PLC[/E1] activity and cytosolic PI-PLC and [E2]PIP2-PLC[/E2]", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "PIP2-PLC", "entity_1_idx": [[46, 54]], "entity_1_idx_in_text_with_entity_marker": [50, 58], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "PIP2-PLC", "entity_2_idx": [[89, 97]], "entity_2_idx_in_text_with_entity_marker": [102, 110], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d131.s316_IEPA.d131.s316.p0", "text": "Vasopressin stimulates tyrosine phosphorylation by activation of PKC in the rat smooth muscle cell line, A-10", "text_with_entity_marker": "[E1]Vasopressin[/E1] stimulates tyrosine phosphorylation by activation of [E2]PKC[/E2] in the rat smooth muscle cell line, A-10", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "Vasopressin", "entity_1_idx": [[0, 11]], "entity_1_idx_in_text_with_entity_marker": [4, 15], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "PKC", "entity_2_idx": [[65, 68]], "entity_2_idx_in_text_with_entity_marker": [78, 81], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d137.s325_IEPA.d137.s325.p0", "text": "We previously showed that arginine vasopressin (AVP) stimulates heat shock protein 27 (HSP27) induction through protein kinase C activation in aortic smooth muscle A10 cells", "text_with_entity_marker": "We previously showed that [E1]arginine vasopressin[/E1] (AVP) stimulates heat shock protein 27 (HSP27) induction through [E2]protein kinase C[/E2] activation in aortic smooth muscle A10 cells", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "arginine vasopressin", "entity_1_idx": [[26, 46]], "entity_1_idx_in_text_with_entity_marker": [30, 50], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "protein kinase C", "entity_2_idx": [[112, 128]], "entity_2_idx_in_text_with_entity_marker": [125, 141], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d138.s328_IEPA.d138.s328.p5", "text": "In addition, glycosyl-phosphatidylinositol-specific phospholipase C (GPI-PLC), which in isolated rat adipocytes is activated by insulin, was stimulated to up to 5-fold by glucose and 10-fold by glucose plus insulin in both yeast spheroplasts and intact cells leading to a concentration-dependent leftward shift of the glucose-response curve for activation of the GPI-PLC", "text_with_entity_marker": "In addition, glycosyl-phosphatidylinositol-specific phospholipase C (GPI-PLC), which in isolated rat adipocytes is activated by insulin, was stimulated to up to 5-fold by glucose and 10-fold by glucose plus [E1]insulin[/E1] in both yeast spheroplasts and intact cells leading to a concentration-dependent leftward shift of the glucose-response curve for activation of the [E2]GPI-PLC[/E2]", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "insulin", "entity_1_idx": [[207, 214]], "entity_1_idx_in_text_with_entity_marker": [211, 218], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "GPI-PLC", "entity_2_idx": [[363, 370]], "entity_2_idx_in_text_with_entity_marker": [376, 383], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d139.s334_IEPA.d139.s334.p0", "text": "A negative correlation between WAT O2 consumption and UCP2 expression was found in control animals, but not in the cafeteria-fed groups, suggesting a differential response to the beta3-adrenergic compound in lean and obese animals, which is in agreement with the reported statistical interactions between obesity and Trecadrine administration found for WAT O2 consumption and muscle UCP2 expression, as well as for plasma leptin and WAT leptin expression", "text_with_entity_marker": "A negative correlation between WAT O2 consumption and [E1]UCP2[/E1] expression was found in control animals, but not in the cafeteria-fed groups, suggesting a differential response to the beta3-adrenergic compound in lean and obese animals, which is in agreement with the reported statistical interactions between obesity and Trecadrine administration found for WAT O2 consumption and muscle [E2]UCP2[/E2] expression, as well as for plasma leptin and WAT leptin expression", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "UCP2", "entity_1_idx": [[54, 58]], "entity_1_idx_in_text_with_entity_marker": [58, 62], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "UCP2", "entity_2_idx": [[383, 387]], "entity_2_idx_in_text_with_entity_marker": [396, 400], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d139.s334_IEPA.d139.s334.p5", "text": "A negative correlation between WAT O2 consumption and UCP2 expression was found in control animals, but not in the cafeteria-fed groups, suggesting a differential response to the beta3-adrenergic compound in lean and obese animals, which is in agreement with the reported statistical interactions between obesity and Trecadrine administration found for WAT O2 consumption and muscle UCP2 expression, as well as for plasma leptin and WAT leptin expression", "text_with_entity_marker": "A negative correlation between WAT O2 consumption and UCP2 expression was found in control animals, but not in the cafeteria-fed groups, suggesting a differential response to the beta3-adrenergic compound in lean and obese animals, which is in agreement with the reported statistical interactions between obesity and Trecadrine administration found for WAT O2 consumption and muscle UCP2 expression, as well as for plasma [E1]leptin[/E1] and WAT [E2]leptin[/E2] expression", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "leptin", "entity_1_idx": [[422, 428]], "entity_1_idx_in_text_with_entity_marker": [426, 432], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "leptin", "entity_2_idx": [[437, 443]], "entity_2_idx_in_text_with_entity_marker": [450, 456], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d143.s343_IEPA.d143.s343.p0", "text": "Oxytocin central injections to intact animals stimulated insulin synthesis and secretion without changing of islets area", "text_with_entity_marker": "[E1]Oxytocin[/E1] central injections to intact animals stimulated [E2]insulin[/E2] synthesis and secretion without changing of islets area", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "Oxytocin", "entity_1_idx": [[0, 8]], "entity_1_idx_in_text_with_entity_marker": [4, 12], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "insulin", "entity_2_idx": [[57, 64]], "entity_2_idx_in_text_with_entity_marker": [70, 77], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d146.s355_IEPA.d146.s355.p1", "text": "Pretreatment for 24 h with 1 microM PMA downregulated expression of PKC-alpha and -delta, but not PKC-epsilon, and prevented the Ca2+-spiking responses to either 1 nM PMA or 100 pM AVP", "text_with_entity_marker": "Pretreatment for 24 h with 1 microM PMA downregulated expression of [E1]PKC-alpha[/E1] and -delta, but not PKC-epsilon, and prevented the Ca2+-spiking responses to either 1 nM PMA or 100 pM [E2]AVP[/E2]", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "PKC-alpha", "entity_1_idx": [[68, 77]], "entity_1_idx_in_text_with_entity_marker": [72, 81], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "AVP", "entity_2_idx": [[181, 184]], "entity_2_idx_in_text_with_entity_marker": [194, 197], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d146.s356_IEPA.d146.s356.p0", "text": "We conclude that PKC activation is a necessary step in the signal transduction pathway linking low concentrations of AVP to Ca2+ spiking in A7r5 cells", "text_with_entity_marker": "We conclude that [E1]PKC[/E1] activation is a necessary step in the signal transduction pathway linking low concentrations of [E2]AVP[/E2] to Ca2+ spiking in A7r5 cells", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "PKC", "entity_1_idx": [[17, 20]], "entity_1_idx_in_text_with_entity_marker": [21, 24], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "AVP", "entity_2_idx": [[117, 120]], "entity_2_idx_in_text_with_entity_marker": [130, 133], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d161.s387_IEPA.d161.s387.p1", "text": "Using reverse transcriptase-polymerase chain reaction analysis, the mRNA expression of fatty acid translocase (FAT)/CD36, PPAR-gamma2, leptin, uncoupling protein (UCP)-2 and UCP-3, and tumor necrosis factor (TNF)-alpha was investigated in gluteal subcutaneous fat biopsies before and after 5 h infusions of saline or Intralipid (Pharmacia and Upjohn, Milan, Italy) plus heparin, which does not modify insulinemia", "text_with_entity_marker": "Using reverse transcriptase-polymerase chain reaction analysis, the mRNA expression of fatty acid translocase (FAT)/CD36, PPAR-gamma2, [E1]leptin[/E1], uncoupling protein (UCP)-2 and [E2]UCP-3[/E2], and tumor necrosis factor (TNF)-alpha was investigated in gluteal subcutaneous fat biopsies before and after 5 h infusions of saline or Intralipid (Pharmacia and Upjohn, Milan, Italy) plus heparin, which does not modify insulinemia", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "leptin", "entity_1_idx": [[135, 141]], "entity_1_idx_in_text_with_entity_marker": [139, 145], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "UCP-3", "entity_2_idx": [[174, 179]], "entity_2_idx_in_text_with_entity_marker": [187, 192], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d167.s403_IEPA.d167.s403.p1", "text": "Pretreatment of HEK-293 cells for 2 min with carbachol, a mAChR agonist, lysophosphatidic acid, or ATP, followed by agonist washout, strongly increased (by 2-3-fold) maximal PLC stimulation (measured >/=40 min later) by epidermal growth factor and platelet-derived growth factor, but not insulin, and largely enhanced PLC sensitivity to these RTK agonists", "text_with_entity_marker": "Pretreatment of HEK-293 cells for 2 min with carbachol, a mAChR agonist, lysophosphatidic acid, or ATP, followed by agonist washout, strongly increased (by 2-3-fold) maximal [E1]PLC[/E1] stimulation (measured >/=40 min later) by epidermal growth factor and platelet-derived growth factor, but not insulin, and largely enhanced [E2]PLC[/E2] sensitivity to these RTK agonists", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "PLC", "entity_1_idx": [[174, 177]], "entity_1_idx_in_text_with_entity_marker": [178, 181], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "PLC", "entity_2_idx": [[318, 321]], "entity_2_idx_in_text_with_entity_marker": [331, 334], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d167.s403_IEPA.d167.s403.p2", "text": "Pretreatment of HEK-293 cells for 2 min with carbachol, a mAChR agonist, lysophosphatidic acid, or ATP, followed by agonist washout, strongly increased (by 2-3-fold) maximal PLC stimulation (measured >/=40 min later) by epidermal growth factor and platelet-derived growth factor, but not insulin, and largely enhanced PLC sensitivity to these RTK agonists", "text_with_entity_marker": "Pretreatment of HEK-293 cells for 2 min with carbachol, a mAChR agonist, lysophosphatidic acid, or ATP, followed by agonist washout, strongly increased (by 2-3-fold) maximal PLC stimulation (measured >/=40 min later) by epidermal growth factor and platelet-derived growth factor, but not [E1]insulin[/E1], and largely enhanced [E2]PLC[/E2] sensitivity to these RTK agonists", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "insulin", "entity_1_idx": [[288, 295]], "entity_1_idx_in_text_with_entity_marker": [292, 299], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "PLC", "entity_2_idx": [[318, 321]], "entity_2_idx_in_text_with_entity_marker": [331, 334], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d170.s413_IEPA.d170.s413.p0", "text": "We investigated basal levels of serum leptin, CCK, galanin and NPY in 16 non-obese premenopausal women, in 15 obese premenopausal women (body mass index (BMI) 34.6 +/- 1.3 SD) and in ten obese postmenopausal women (BMI 34.7 +/- 1.5 SD) to determine the relationship between obesity, menopause and these neuropeptides", "text_with_entity_marker": "We investigated basal levels of serum [E1]leptin[/E1], CCK, galanin and [E2]NPY[/E2] in 16 non-obese premenopausal women, in 15 obese premenopausal women (body mass index (BMI) 34.6 +/- 1.3 SD) and in ten obese postmenopausal women (BMI 34.7 +/- 1.5 SD) to determine the relationship between obesity, menopause and these neuropeptides", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "leptin", "entity_1_idx": [[38, 44]], "entity_1_idx_in_text_with_entity_marker": [42, 48], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "NPY", "entity_2_idx": [[63, 66]], "entity_2_idx_in_text_with_entity_marker": [76, 79], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d174.s423_IEPA.d174.s423.p0", "text": "The total intake of flavonoids was inversely correlated with the plasma total cholesterol concentration (TC) (r = -0.236, P: < 0.05) and plasma LDL cholesterol concentration (LDL-C) (r = -0.220, P: < 0.05), after the adjustment for age, body mass index and total energy intake", "text_with_entity_marker": "The total intake of [E1]flavonoids[/E1] was inversely correlated with the plasma total [E2]cholesterol[/E2] concentration (TC) (r = -0.236, P: < 0.05) and plasma LDL cholesterol concentration (LDL-C) (r = -0.220, P: < 0.05), after the adjustment for age, body mass index and total energy intake", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "flavonoids", "entity_1_idx": [[20, 30]], "entity_1_idx_in_text_with_entity_marker": [24, 34], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "cholesterol", "entity_2_idx": [[78, 89]], "entity_2_idx_in_text_with_entity_marker": [91, 102], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d174.s423_IEPA.d174.s423.p1", "text": "The total intake of flavonoids was inversely correlated with the plasma total cholesterol concentration (TC) (r = -0.236, P: < 0.05) and plasma LDL cholesterol concentration (LDL-C) (r = -0.220, P: < 0.05), after the adjustment for age, body mass index and total energy intake", "text_with_entity_marker": "The total intake of [E1]flavonoids[/E1] was inversely correlated with the plasma total cholesterol concentration (TC) (r = -0.236, P: < 0.05) and plasma LDL [E2]cholesterol[/E2] concentration (LDL-C) (r = -0.220, P: < 0.05), after the adjustment for age, body mass index and total energy intake", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "flavonoids", "entity_1_idx": [[20, 30]], "entity_1_idx_in_text_with_entity_marker": [24, 34], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "cholesterol", "entity_2_idx": [[148, 159]], "entity_2_idx_in_text_with_entity_marker": [161, 172], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d180.s433_IEPA.d180.s433.p0", "text": "Circadian fluctuations of NPY and leptin levels maintain normal body homeostasis", "text_with_entity_marker": "Circadian fluctuations of [E1]NPY[/E1] and [E2]leptin[/E2] levels maintain normal body homeostasis", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "NPY", "entity_1_idx": [[26, 29]], "entity_1_idx_in_text_with_entity_marker": [30, 33], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "leptin", "entity_2_idx": [[34, 40]], "entity_2_idx_in_text_with_entity_marker": [47, 53], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d183.s437_IEPA.d183.s437.p0", "text": "Plasma insulin, cholecystokinin, galanin, neuropeptide Y and leptin levels in obese women with and without type 2 diabetes mellitus", "text_with_entity_marker": "Plasma insulin, cholecystokinin, galanin, [E1]neuropeptide Y[/E1] and [E2]leptin[/E2] levels in obese women with and without type 2 diabetes mellitus", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "neuropeptide Y", "entity_1_idx": [[42, 56]], "entity_1_idx_in_text_with_entity_marker": [46, 60], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "leptin", "entity_2_idx": [[61, 67]], "entity_2_idx_in_text_with_entity_marker": [74, 80], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d185.s443_IEPA.d185.s443.p1", "text": "ARC NPY neurones also mediate hyperphagia and obesity in the ob/ob and db/db mice and fa/fa rat, in which leptin inhibition is lost through mutations affecting leptin or its receptor", "text_with_entity_marker": "ARC [E1]NPY[/E1] neurones also mediate hyperphagia and obesity in the ob/ob and db/db mice and fa/fa rat, in which leptin inhibition is lost through mutations affecting [E2]leptin[/E2] or its receptor", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "NPY", "entity_1_idx": [[4, 7]], "entity_1_idx_in_text_with_entity_marker": [8, 11], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "leptin", "entity_2_idx": [[160, 166]], "entity_2_idx_in_text_with_entity_marker": [173, 179], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d187.s447_IEPA.d187.s447.p0", "text": "The expression of alpha-amylase in aleurone layers of barley is known to be induced by gibberellin A3 (GA).", "text_with_entity_marker": "The expression of [E1]alpha-amylase[/E1] in aleurone layers of barley is known to be induced by [E2]gibberellin A3[/E2] (GA).", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "alpha-amylase", "entity_1_idx": [[18, 31]], "entity_1_idx_in_text_with_entity_marker": [22, 35], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "gibberellin A3", "entity_2_idx": [[87, 101]], "entity_2_idx_in_text_with_entity_marker": [100, 114], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d189.s453_IEPA.d189.s453.p2", "text": "These findings are consistent with increased leptin signaling to the NPY and POMC neurons in the ARC by physiological levels of circulating leptin during normal feeding", "text_with_entity_marker": "These findings are consistent with increased leptin signaling to the [E1]NPY[/E1] and POMC neurons in the ARC by physiological levels of circulating [E2]leptin[/E2] during normal feeding", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "NPY", "entity_1_idx": [[69, 72]], "entity_1_idx_in_text_with_entity_marker": [73, 76], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "leptin", "entity_2_idx": [[140, 146]], "entity_2_idx_in_text_with_entity_marker": [153, 159], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d192.s461_IEPA.d192.s461.p0", "text": "Relative to the wild type, the GA(3)-treated aleurone layer of d1 had lower expression of Ramy1A, which encodes alpha-amylase, and OsGAMYB, which encodes a GA-inducible transcriptional factor, and no increase in expression of Ca(2 +)-ATPase", "text_with_entity_marker": "Relative to the wild type, the [E1]GA[/E1](3)-treated aleurone layer of d1 had lower expression of Ramy1A, which encodes [E2]alpha-amylase[/E2], and OsGAMYB, which encodes a GA-inducible transcriptional factor, and no increase in expression of Ca(2 +)-ATPase", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "GA", "entity_1_idx": [[31, 33]], "entity_1_idx_in_text_with_entity_marker": [35, 37], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "alpha-amylase", "entity_2_idx": [[112, 125]], "entity_2_idx_in_text_with_entity_marker": [125, 138], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d193.s464_IEPA.d193.s464.p0", "text": "Finally, recent evidences suggest that melanocortins could be involved in mediating the effects of leptin, and in controlling the expression of neuropeptide Y (NPY)", "text_with_entity_marker": "Finally, recent evidences suggest that melanocortins could be involved in mediating the effects of [E1]leptin[/E1], and in controlling the expression of [E2]neuropeptide Y[/E2] (NPY)", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "leptin", "entity_1_idx": [[99, 105]], "entity_1_idx_in_text_with_entity_marker": [103, 109], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "neuropeptide Y", "entity_2_idx": [[144, 158]], "entity_2_idx_in_text_with_entity_marker": [157, 171], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d194.s466_IEPA.d194.s466.p0", "text": "Co-expression of PLD1 with phospholipase C (PLC)gamma has the same effect, while co-expression of PLD2 with PLCgamma allows PLD2 activity to be stimulated in an insulin-dependent manner.", "text_with_entity_marker": "Co-expression of PLD1 with [E1]phospholipase C (PLC)gamma[/E1] has the same effect, while co-expression of PLD2 with [E2]PLCgamma[/E2] allows PLD2 activity to be stimulated in an insulin-dependent manner.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "phospholipase C (PLC)gamma", "entity_1_idx": [[27, 53]], "entity_1_idx_in_text_with_entity_marker": [31, 57], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "PLCgamma", "entity_2_idx": [[108, 116]], "entity_2_idx_in_text_with_entity_marker": [121, 129], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d197.s482_IEPA.d197.s482.p0", "text": "These results disclose the potential of the PrP to modulate the activity of CK2, a pleiotropic protein kinase that is particularly abundant in the brain", "text_with_entity_marker": "These results disclose the potential of the [E1]PrP[/E1] to modulate the activity of [E2]CK2[/E2], a pleiotropic protein kinase that is particularly abundant in the brain", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "PrP", "entity_1_idx": [[44, 47]], "entity_1_idx_in_text_with_entity_marker": [48, 51], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "CK2", "entity_2_idx": [[76, 79]], "entity_2_idx_in_text_with_entity_marker": [89, 92], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
